NewLimit

Epigenetic reprogramming biotech using machine learning and cell biology to develop medicines that extend healthspan.

Pricing

Custom pricing

Founded

2021

Team size

51-200 employees

About NewLimit

Epigenetic reprogramming biotech using machine learning and cell biology to develop medicines that extend healthspan.

South San Francisco, CA

Track this product in your Cubbie stack workspace. Monitor usage, renewals, and spending.

Earn 1% back as Cubbie Points on every purchase. Redeem for policy-aware personal rewards, premium travel, company credits, and more.

Are you the vendor? Claim this profile to manage your listing, publish deals, and track case studies.